ArticleBMC public health2025
Evaluation of the community-based suicide surveillance system in Northern Thailand using the RE-AIM framework.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimizing liposomal bupivacaine in thoracoscopic enhanced recovery: precision stratification, protocol standardization, and equitable access: A Letter to the Editor about "Effect of liposomal bupivacaine for preoperative erector spinae plane block on postoperative pain following video-assisted thoracoscopic lung resection: a multicenter, randomized, double-blind, clinical trial".International journal of surgery (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuicide is a significant public health concern globally, with disproportionate impacts in low- and middle-income countries. Thailand's suicide rate has risen steadily, particularly in northern provinces such as Lamphun. In response, the Lamphun Provincial Health Office developed the "Four Pillars," a community-based, multisectoral suicide prevention strategy. This study evaluates the feasibility and effectiveness of the Four Pillars using the RE-AIM framework.
methodsA convergent parallel mixed-methods study was conducted across three districts in Lamphun Province. Quantitative data included suicide surveillance reports from 2020-2022 and a community survey of 600 adults. Qualitative data were collected through in-depth interviews (n = 36), three focus group discussions (n = 21), and document reviews. The RE-AIM framework guided tool development, data collection, and analysis, evaluating the strategy across five dimensions: Reach, Effectiveness, Adoption, Implementation, and Maintenance
resultsReach: A total of 2,876 individuals at suicide risk were identified and received integrative interventions. EFFECTIVENESS: None subsequently exhibited suicidal behavior. Suicide rates in Lamphun declined modestly post-implementation, though not significantly (p = 0.331). Adoption: Adoption varied due to cultural beliefs, resource limitations, and stigma; survey findings revealed lower suicide literacy and persistent stigma in ethnic communities (p < 0.01). IMPLEMENTATION: Community-based surveillance was successfully adapted across contexts (e.g., via local language dissemination, engaging monks and street vendors as gatekeepers) with high fidelity to the model's core principles. Strong partnerships were critical.
conclusionsThe Four Pillars strategy is a feasible and promising approach to reduce suicide risk through a community-based integrated surveillance and response system. Strategic local adaptations enhanced its feasibility without compromising core components. Addressing stigma, improving literacy, and strengthening multisectoral capacity are critical for broader scale-up and sustainability in Thailand and similar settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.